XPO1 and Hodgkins lymphoma: In addition, Camus V. also demonstrated that classical HL patients with XPO1 mutations, detected by dPCR in cfDNA from plasma collected at the end of standard chemotherapy, had a shorter PFS compared to unmutated XPO1 cases [23].